Search

Calmare NJ USA

Tag

nyc pain management

Calmare NJ Accept Patients from Travel Advisory States

August 17, 2020

Understandably, traveling to New Jersey (or anywhere, for that matter) these days is complex. We’ve recently received calls from upcoming patients who are confused about their ability to enter our state if they are traveling from one of the 31 states (as of 8/17/20) listed on the New York, New Jersey, Connecticut Travel Advisory List.

Important Note:  Traveling to New York/New Jersey to undergo healthcare treatment is permissible; the self-quarantine is voluntary and compliance is expected.

“Travelers from impacted states should self-quarantine at a hotel, or other temporary lodging. Individuals should only leave the place of self-quarantine to seek medical care/treatment or to obtain food and other essential items.”

NJ State COVID-19 Information Hub

We do recommend that you speak with your local lodging provider about any COVID-19 operational changes and current precautionary measures.

Should you need recommendations for local hotels, please visit our New Patients page and click on Hotel & Travel Information.

Andrea is a registered nurse RN from PA who came to New Jersey for Calmare Therapy performed by Dr. Michael Cooney
Registered Nurse Andrea was here from PA in July 2020.

The Good News

Dr. Cooney and the Calmare team use every precautionary measure to protect patients and staff from possible virus transmission.

The Governor of New Jersey has been very conservative regarding the reopening phases for our state (no indoor dining, indoor gyms or indoor gatherings of more than 25 people).

Right now, our state’s transmission rate is below 1%, after a blip upward around the Fourth of July. This is one of the lowest COVID rates in the nation at this time.

At our clinic, we continue to treat only one patient in the clinic at a time and follow all CDC and State of NJ Department of Health precautionary guidelines.

Since we are keeping our staff as bare bones as possible, you may only come into direct contact with Dr. Michael Cooney, our clinical director, since he is the sole treatment provider.

Certainly, we are living in crazy times. But many people are still living with uncontrolled chronic pain. We can’t “wait” to help people in pain, living day-after-day with a diminished quality of life.

Therefore, following state requirements, we are continuing to move forward, treating our patients with fastidious care, supported by COVID precautionary measures in place.

Rhonda adds her pin to California on the Calmare Patient Map. Summer 2020

Pain waits for no one, not even a pandemic. But we will fight back with a safe and comforting environment to provide treatment, just like we have since 2011.

Please feel free to contact Dr. Cooney directly if you have questions or concerns about your future Calmare Therapy treatments.

Email:  info@calmaretherapynj.com

PH: 201.933.4440

Until we welcome you to New Jersey, stay safe, stay secure and may you have many low-pain days and nights.

Featured post

ADDED DATES: Fibromyalgia Clinical Trial at Calmare NJ USA

May 3, 2018

CLINICAL TRIAL – DIAGNOSED FIBROMYALGIA

Study 

To Measure Chronic Pain Reduction in Patients Diagnosed with Treatment-Resistant Fibromyalgia after Administering 3-5 Calmare (Scrambler Therapy) Treatments

Phase

Pilot

What is Fibromyalgia?

Fibromyalgia is a disorder characterized by widespread musculoskeletal pain accompanied by fatigue, sleep, memory and mood issues. Researchers believe that fibromyalgia amplifies painful sensations by affecting the way your brain processes pain signals.

Calmare scrambler therapy is a drug-free, non-invasive, FDA-cleared therapy that painlessly scrambles a misfiring pain message from the brain, suggesting there is pain, when, in fact, there is not.

Purpose of the Clinical Trial

To document the viability of using scrambler therapy as a pain management solution to significantly reduce or eliminate neuropathic pain in patients diagnosed with Fibromyalgia.

Study Conducted by

Michael J. Cooney, D.C., Clinical Director

Rutherford Allied Medical Group  | Calmare Therapy NJ USA

 Location

323 Union Ave., Rutherford, New Jersey (10 miles from New York City)

Trial Start Date (Rolling Admission)

May 21, 2018 to August 31, 2018

Testing Period

After a personal consultation and evaluation by Dr. Michael Cooney, selected trial candidates will undergo 3 to 5 treatments, once daily, lasting approximately 35 minutes. Additional treatments will be at the discretion of the clinical director.

Calmare Therapy NJ Background

Calmare Therapy NJ / Rutherford Allied Medical Group, is one of only eight certified providers of Calmare Pain Therapy Treatment®, an FDA-cleared, non-invasive, pain-free, drug-free technology to treat patients suffering from several types of long-term, high-intensity pain.

Scope of the Calmare Fibromyalgia Clinical Trial

We are conducting a no-cost, 3 or more treatments (one 35-minute daily therapy session) clinical trial study for pre-qualified patients suffering from diagnosed fibromyalgia FMS to determine the efficacy of scrambler therapy as a viable treatment solution for condition-induced neuropathy.

Trial participants are selected at the discretion of Dr. Michael Cooney, clinical director, Calmare Therapy NJ USA | Application Form

Eligibility Criteria

Selected clinical trial volunteers must be available to undergo the protocol once per day. We will make every effort to schedule daily appointments at a convenient time for participants.

Travel, daily transportation, meals and accommodations are at the trial participant’s expense.

Contraindications

We are seeking trial candidates with few or no additional medical conditions, in order to maximize the treatment and outcome of the FMS condition exclusively.

Candidates are not eligible for the trial if they have the following medical conditions, devices or prescribed medications:

  • Pacemaker
  • Automatic implantable cardioverter-defibrillator (AICD)
  • Pregnancy
  • Epilepsy
  • Heart conditions
  • Anticonvulsants
  • Antidepressants

Informed Consent

Clinical trial volunteers who are selected for the study are asked to sign the Informed Consent Form. Signing this document does not require participants to remain for the duration of the study, however.

People can leave the study at any time—either before the study starts or at any time during the study or the follow-up period. The informed consent process continues throughout the study. If new benefits, risks, or side effects are discovered during the study, the researchers must inform the participants.

Publicity

Calmare Therapy NJ reserves the right to publish data about any participant’s trial outcome. We will not include your name or image, at your request.

To Apply / Contact Us / For More Information

There is no fee to participate. 

To apply for the trial, click here to complete and scan the attached application form and return it to calmarenj@gmail.com or fax to (201) 933-8159.

For questions about the trial, please contact:

Dr. Michael Cooney

Clinical Director

Calmare Therapy NJ / Rutherford Allied Medical Group

(201) 933.4440   |   calmarenj@gmail.com

 

 

 

Blog at WordPress.com.

Up ↑

<span>%d</span> bloggers like this: